We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.95%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.5B
AUM Growth
-$470M
(-0.57%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.85%
Holding
751
New
67
Increased
353
Reduced
251
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$531M |
| 2 |
Microchip Technology
MCHP
|
+$311M |
| 3 |
Check Point Software Technologies
CHKP
|
+$243M |
| 4 |
Sanofi
SNY
|
+$224M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$364M |
| 2 |
Vertiv
VRT
|
+$292M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$274M |
| 4 |
HF Sinclair
DINO
|
+$253M |
| 5 |
TGNA
TEGNA Inc
TGNA
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.6% |
| 2 | Healthcare | 16.65% |
| 3 | Technology | 14.96% |
| 4 | Industrials | 14.22% |
| 5 | Energy | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Best Buy
BBY
$18.8B
| – | – |
-722,157
| Closed | -$73.4M |
|
702
Bausch Health
BHC
$1.69B
| – | – |
-61,447
| Closed | -$1.7M |
|
703
Biogen
BIIB
$29.8B
| – | – |
-313,782
| Closed | -$75.3M |
|
704
Caleres
CAL
$443M
| – | – |
-93,874
| Closed | -$2.13M |
|
705
CF Industries
CF
$18.8B
| – | – |
-8,560
| Closed | -$606K |
|
706
Chord Energy
CHRD
$7.25B
| – | – |
-4,090
| Closed | -$515K |
|
707
eBay
EBAY
$51.8B
| – | – |
-42,564
| Closed | -$2.83M |
|
708
eHealth
EHTH
$43.8M
| – | – |
-26,037
| Closed | -$238K |
|
709
Enova International
ENVA
$6.18B
| – | – |
-29,266
| Closed | -$1.2M |
|
710
1-800-Flowers.com
FLWS
$255M
| – | – |
-87,625
| Closed | -$2.05M |
|
711
Fossil Group
FOSL
$255M
| – | – |
-34,549
| Closed | -$356K |
|
|
GPMT
712
Granite Point Mortgage Trust
GPMT
$63.3M
| – | – |
-52,128
| Closed | -$610K |
|
713
Herbalife
HLF
$1.29B
| – | – |
-21,725
| Closed | -$889K |
|
714
Helmerich & Payne
HP
$3.28B
| – | – |
-1,200,908
| Closed | -$29M |
|
715
iQIYI
IQ
$1.21B
| – | – |
-217,239
| Closed | -$130K |
|
716
iShares Core S&P US Value ETF
IUSV
$27.5B
| – | – |
-4,864
| Closed | -$373K |
|
|
KC
717
Kingsoft Cloud Holdings
KC
$3.01B
| – | – |
-55,183
| Closed | -$17K |
|
718
Lowe's Companies
LOW
$121B
| – | – |
-2,058
| Closed | -$532K |
|
719
Northrop Grumman
NOC
$78.2B
| – | – |
-542
| Closed | -$210K |
|
720
Insperity
NSP
$2B
| – | – |
-7,782
| Closed | -$919K |
|
721
Nu Holdings
NU
$70.8B
| – | – |
-15,000
| Closed | -$141K |
|
722
Peoples Bancorp
PEBO
$1.51B
| – | – |
-42,231
| Closed | -$1.34M |
|
723
Playtika
PLTK
$1.51B
| – | – |
-86,248
| Closed | -$62K |
|
724
PayPal
PYPL
$51.8B
| – | – |
-1,421
| Closed | -$268K |
|
725
Quantum Corp
QMCO
$439M
| – | – |
-3,788
| Closed | -$418K |
|
Similar funds
Boston Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Boston Partners held 751 positions worth $82.5B, down 0.57% from $83B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q1 2022 filing shows 67 new, 353 increased, 251 reduced and 53 closed positions. Its largest new stake was Microchip Technology: 4,127,908 shares worth $310M. The largest sale was Citigroup, an estimated $364M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2022 buy was Microchip Technology: 4,127,908 shares worth $310M.
- Boston Partners added most to Procter & Gamble in Q1 2022, an estimated $531M increase.
- Boston Partners's biggest Q1 2022 reduction was Citigroup, cutting an estimated $364M.
- Boston Partners fully exited Vertiv in Q1 2022, selling an estimated $292M.
- Boston Partners's ten largest holdings make up 14% of its $82.5B portfolio in Q1 2022.
- Boston Partners opened 67 new positions and closed 53 in Q1 2022.
- Boston Partners's portfolio value fell 0.57% quarter-over-quarter to $82.5B.
Based on Boston Partners's 13F filing for Q1 2022, filed 10 May 2022.